MYGN RSI Chart
Last 7 days
1.2%
Last 30 days
-2.3%
Last 90 days
-9.9%
Trailing 12 Months
8.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 694.7M | 698.9M | 734.4M | 753.2M |
2022 | 682.4M | 672.3M | 661.4M | 678.4M |
2021 | 566.1M | 662.3M | 684.4M | 690.6M |
2020 | 760.8M | 638.6M | 597.5M | 557.0M |
2019 | 829.6M | 851.1M | 835.1M | 813.4M |
2018 | 749.4M | 743.7M | 767.2M | 796.1M |
2017 | 743.5M | 769.9M | 769.8M | 761.0M |
2016 | 756.6M | 740.5M | 735.9M | 739.3M |
2015 | 721.9M | 722.5M | 737.2M | 746.1M |
2014 | 763.6M | 778.2M | 744.5M | 724.9M |
2013 | 572.0M | 613.2M | 682.2M | 737.1M |
2012 | 470.5M | 496.0M | 519.0M | 545.3M |
2011 | 388.6M | 402.1M | 420.7M | 443.0M |
2010 | 353.6M | 362.6M | 369.4M | 377.1M |
2009 | 0 | 326.5M | 335.6M | 344.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 14, 2024 | verratti mark | sold (taxes) | -21,035 | 19.55 | -1,076 | chief commercial officer |
Apr 14, 2024 | muzzey dale | sold (taxes) | -18,377 | 19.55 | -940 | chief scientific officer |
Apr 06, 2024 | munk natalie | sold (taxes) | -11,771 | 20.26 | -581 | chief accounting officer |
Mar 25, 2024 | munk natalie | sold (taxes) | -7,978 | 21.98 | -363 | chief accounting officer |
Mar 24, 2024 | diaz paul j | sold (taxes) | -1,019,080 | 22.24 | -45,822 | president and ceo |
Mar 24, 2024 | haas kevin richard | sold (taxes) | -64,273 | 22.24 | -2,890 | chief technology officer |
Mar 24, 2024 | muzzey dale | sold (taxes) | -20,972 | 22.24 | -943 | chief scientific officer |
Mar 24, 2024 | verratti mark | sold (taxes) | -72,168 | 22.24 | -3,245 | chief commercial officer |
Mar 24, 2024 | munk natalie | sold (taxes) | -21,817 | 22.24 | -981 | chief accounting officer |
Mar 22, 2024 | diaz paul j | sold (taxes) | -449,292 | 22.24 | -20,202 | president and ceo |
Which funds bought or sold MYGN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | TEXAS PERMANENT SCHOOL FUND CORP | added | 1.16 | 185,933 | 1,651,980 | 0.01% |
May 06, 2024 | HighTower Advisors, LLC | reduced | -4.23 | 21,000 | 316,000 | -% |
May 06, 2024 | TEACHER RETIREMENT SYSTEM OF TEXAS | added | 4.06 | 58,000 | 420,000 | -% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | reduced | -14.29 | -6.00 | 128 | -% |
May 06, 2024 | SG Americas Securities, LLC | reduced | -36.65 | -194,000 | 465,000 | -% |
May 06, 2024 | Parallel Advisors, LLC | reduced | -4.08 | 1,060 | 16,544 | -% |
May 03, 2024 | VICTORY CAPITAL MANAGEMENT INC | reduced | -24.84 | -263,533 | 1,355,460 | -% |
May 03, 2024 | SIGNATUREFD, LLC | unchanged | - | 131 | 1,279 | -% |
May 03, 2024 | Glassman Wealth Services | sold off | -100 | -1,168 | - | -% |
May 03, 2024 | OREGON PUBLIC EMPLOYEES RETIREMENT FUND | reduced | -8.86 | 7,565 | 504,516 | 0.01% |
Unveiling Myriad Genetics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Myriad Genetics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.3B | 23.7B | 41.87 | 7.76 | ||||
A | 41.4B | 6.7B | 33.5 | 6.15 | ||||
IDXX | 40.0B | 3.7B | 46.15 | 10.74 | ||||
DGX | 15.2B | 9.3B | 17.98 | 1.64 | ||||
MEDP | 12.5B | 2.0B | 39.87 | 6.35 | ||||
CRL | 12.1B | 4.1B | 25.56 | 2.94 | ||||
NTRA | 11.7B | 1.1B | -27 | 10.84 | ||||
EXAS | 11.1B | 2.5B | -54.61 | 4.46 | ||||
MID-CAP | ||||||||
NEOG | 2.7B | 929.2M | 1.7K | 2.89 | ||||
GH | 2.3B | 563.9M | -4.78 | 4.06 | ||||
SMALL-CAP | ||||||||
CDNA | 542.6M | 280.3M | -2.85 | 1.94 | ||||
ACRS | 95.5M | 31.1M | -1.24 | 3.07 | ||||
APDN | 61.1M | 9.0M | -8.46 | 6.79 | ||||
AWH | 36.4M | 9.2M | -2.18 | 3.98 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Myriad Genetics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 2.4% | 196,600,000 | 191,900,000 | 183,500,000 | 181,200,000 | 177,800,000 | 156,400,000 | 179,300,000 | 164,900,000 | 160,800,000 | 167,300,000 | 189,400,000 | 173,100,000 | 154,600,000 | 145,200,000 | 93,200,000 | 164,000,000 | 195,100,000 | 186,300,000 | 215,400,000 | 216,600,000 | 216,800,000 |
Costs and Expenses | -9.5% | 228,000,000 | 252,000,000 | 297,200,000 | 233,400,000 | 230,000,000 | 201,400,000 | 197,100,000 | 190,500,000 | 203,900,000 | 247,200,000 | 210,200,000 | 219,800,000 | 202,800,000 | 184,800,000 | 161,500,000 | 297,700,000 | 203,900,000 | 207,200,000 | 221,000,000 | 210,700,000 | 210,700,000 |
S&GA Expenses | 6.1% | 144,400,000 | 136,100,000 | 140,700,000 | 151,700,000 | 146,500,000 | 130,500,000 | 127,100,000 | 110,600,000 | 75,600,000 | 180,600,000 | 135,200,000 | 146,400,000 | 132,800,000 | 124,100,000 | 107,400,000 | 132,900,000 | 134,300,000 | 135,500,000 | 149,800,000 | 140,600,000 | 135,200,000 |
R&D Expenses | -12.5% | 21,000,000 | 24,000,000 | 21,200,000 | 22,500,000 | 23,400,000 | 20,500,000 | 20,300,000 | 21,200,000 | 20,500,000 | 18,800,000 | 19,500,000 | 23,100,000 | 18,200,000 | 17,600,000 | 17,400,000 | 19,700,000 | 18,800,000 | 21,300,000 | 20,900,000 | 21,500,000 | 22,400,000 |
EBITDA Margin | 12.0% | -0.26 | -0.30 | -0.29 | -0.15 | -0.12 | -0.12 | 0.01 | 0.04 | 0.02 | 0.02 | -0.10 | -0.21 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -10.0% | 900,000 | 1,000,000 | 500,000 | 500,000 | 900,000 | 800,000 | 600,000 | 900,000 | 500,000 | 1,100,000 | 2,000,000 | 3,000,000 | 2,900,000 | 2,900,000 | 3,100,000 | 2,300,000 | 2,500,000 | 2,900,000 | 3,200,000 | 3,200,000 | 3,400,000 |
Income Taxes | -1200.0% | -1,100,000 | 100,000 | - | 2,100,000 | -9,800,000 | -9,100,000 | -3,800,000 | -5,900,000 | -35,900,000 | 15,200,000 | 900,000 | -10,100,000 | -12,500,000 | -28,500,000 | -3,000,000 | -15,900,000 | -3,100,000 | -1,700,000 | -3,400,000 | -3,600,000 | 1,000,000 |
Earnings Before Taxes | 47.2% | -32,300,000 | -61,200,000 | -116,100,000 | -52,600,000 | -52,100,000 | -44,200,000 | -17,900,000 | -26,400,000 | -43,500,000 | 39,800,000 | -3,800,000 | -49,600,000 | -50,400,000 | -43,700,000 | -58,500,000 | -131,100,000 | -11,400,000 | -22,300,000 | -7,700,000 | 3,300,000 | 3,600,000 |
EBT Margin | 9.3% | -0.35 | -0.38 | -0.38 | -0.24 | -0.21 | -0.20 | -0.07 | -0.05 | -0.08 | -0.09 | -0.22 | -0.36 | - | - | - | - | - | - | - | - | - |
Net Income | 49.1% | -31,200,000 | -61,300,000 | -116,100,000 | -54,700,000 | -42,300,000 | -35,100,000 | -14,100,000 | -20,500,000 | -7,600,000 | 24,600,000 | -4,700,000 | -39,500,000 | -37,900,000 | -15,200,000 | -55,400,000 | -115,200,000 | -8,300,000 | -20,600,000 | -4,200,000 | 6,900,000 | 2,600,000 |
Net Income Margin | 6.4% | -0.35 | -0.37 | -0.36 | -0.21 | -0.17 | -0.12 | -0.03 | -0.01 | -0.04 | -0.08 | -0.15 | -0.26 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -147.5% | -54,700,000 | -22,100,000 | -900,000 | -33,200,000 | -7,300,000 | -2,800,000 | -49,700,000 | -46,500,000 | -9,500,000 | -39,300,000 | -4,400,000 | 71,800,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -0.2% | 1,147 | 1,149 | 1,187 | 1,169 | 1,199 | 1,212 | 1,210 | 1,255 | 1,321 | 1,336 | 1,360 | 1,337 | 1,419 | 1,445 | 1,405 | 1,447 | 1,578 | 1,591 | 1,563 | 1,557 | 1,557 |
Current Assets | 18.2% | 314 | 265 | 294 | 262 | 275 | 352 | 367 | 427 | 485 | 499 | 539 | 329 | 389 | 395 | 332 | 355 | 365 | 330 | 349 | 343 | 337 |
Cash Equivalents | 73.8% | 132 | 76.00 | 103 | 54.00 | 57.00 | 109 | 104 | 164 | 257 | 295 | 118 | 149 | 117 | 118 | 164 | 121 | 81.00 | 90.00 | 93.00 | 85.00 | 91.00 |
Inventory | -12.4% | 22.00 | 25.00 | 23.00 | 22.00 | 20.00 | 20.00 | 15.00 | 16.00 | 15.00 | 19.00 | 18.00 | 25.00 | 27.00 | 27.00 | 29.00 | 31.00 | 28.00 | 28.00 | 31.00 | 32.00 | 33.00 |
Net PPE | -1.4% | 119 | 121 | 112 | 96.00 | 83.00 | 68.00 | 53.00 | 46.00 | 44.00 | 43.00 | 43.00 | 45.00 | 41.00 | 37.00 | 37.00 | 37.00 | 37.00 | 55.00 | 57.00 | 59.00 | 59.00 |
Goodwill | 0.3% | 287 | 287 | 287 | 287 | 287 | 237 | 238 | 239 | 239 | 240 | 240 | 328 | 329 | 328 | 328 | 327 | 408 | 416 | 417 | 416 | 413 |
Liabilities | -22.0% | 363 | 466 | 452 | 334 | 313 | 295 | 263 | 305 | 353 | 367 | 458 | 462 | 538 | 535 | 486 | 480 | 501 | 517 | 474 | 476 | 493 |
Current Liabilities | -25.5% | 156 | 209 | 221 | 143 | 137 | 129 | 120 | 166 | 204 | 203 | 271 | 149 | 146 | 134 | 147 | 113 | 112 | 115 | 118 | 109 | 113 |
Long Term Debt | 0% | 39.00 | 39.00 | 38.00 | - | - | - | - | - | - | - | - | 154 | 225 | 225 | 224 | 225 | 225 | 225 | 234 | 263 | 273 |
LT Debt, Non Current | 0% | 39.00 | 39.00 | 38.00 | - | - | - | - | - | - | - | - | - | 225 | - | - | - | - | - | - | - | - |
Shareholder's Equity | 14.6% | 783 | 683 | 735 | 835 | 886 | 917 | 947 | 950 | 968 | 969 | 902 | 875 | 881 | 909 | 918 | 967 | 1,077 | 1,075 | 1,089 | 1,082 | 1,064 |
Retained Earnings | -5.2% | -629 | -598 | -537 | -420 | -366 | -323 | -288 | -274 | -254 | -246 | -271 | -266 | -227 | -189 | -173 | -118 | -3.30 | 5.00 | 26.00 | 30.00 | 23.00 |
Additional Paid-In Capital | 10.1% | 1,416 | 1,286 | 1,277 | 1,263 | 1,260 | 1,251 | 1,244 | 1,232 | 1,226 | 1,219 | 1,177 | 1,145 | 1,110 | 1,101 | 1,097 | 1,093 | 1,085 | 1,076 | 1,068 | 1,057 | 1,046 |
Shares Outstanding | 9.5% | 90.00 | 82.00 | 82.00 | 82.00 | 81.00 | 81.00 | 81.00 | 80.00 | 80.00 | 80.00 | 78.00 | 77.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | -0.10 | -0.10 | - | - | - | - | - | 0.00 | - | - | -0.10 | -0.10 |
Float | - | - | - | 1,898 | - | - | - | 1,465 | - | - | - | 2,377 | - | - | - | 847 | - | 2,030 | - | - | - | 2,130 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -147.5% | -54,700 | -22,100 | -900 | -33,200 | -7,300 | -2,800 | -49,700 | -46,500 | -9,500 | -39,300 | -4,400 | 71,800 | -14,400 | -59,300 | 30,000 | 16,800 | -1,900 | 15,800 | 31,500 | 6,600 | 37,800 |
Share Based Compensation | -10.3% | 10,400 | 11,600 | 11,200 | 7,500 | 8,200 | 9,400 | 10,400 | 10,100 | 8,400 | 10,000 | 8,900 | 9,000 | 6,500 | 8,400 | 1,900 | 7,500 | 7,000 | 8,800 | 8,800 | 9,500 | 7,500 |
Cashflow From Investing | -380.0% | -12,000 | -2,500 | 11,800 | 34,600 | -35,600 | 11,400 | -12,000 | -41,300 | -25,900 | 291,000 | 1,100 | 8,200 | 10,900 | 17,100 | 10,350 | 23,200 | -7,200 | -7,100 | 4,500 | -3,800 | -8,100 |
Cashflow From Financing | 4976.0% | 121,900 | -2,500 | 38,400 | -4,900 | -2,100 | -3,600 | 2,500 | -4,800 | -1,100 | -74,500 | -26,500 | -48,500 | 1,800 | -3,900 | 950 | 200 | 1,100 | -12,300 | -27,800 | -9,400 | -32,600 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 46,150 | -50,000 |
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Total revenue | $ 753.2 | $ 678.4 | $ 690.6 |
Costs and expenses: | |||
Research and development expense | 88.7 | 85.4 | 81.9 |
Selling, general, and administrative expense | 572.9 | 514.7 | 537.8 |
Legal settlements | 112.8 | 0.0 | 62.0 |
Goodwill and long-lived asset impairment charges | 0.0 | 16.9 | 1.8 |
Total costs and expenses | 1,010.6 | 819.0 | 881.1 |
Operating loss | (257.4) | (140.6) | (190.5) |
Other income (expense): | |||
Interest income | 2.5 | 2.6 | 0.7 |
Interest expense | (2.9) | (3.2) | (6.6) |
Other | (4.4) | 0.6 | 139.3 |
Total other income (expense) | (4.8) | 0.0 | 133.4 |
Loss before income tax | (262.2) | (140.6) | (57.1) |
Income tax expense (benefit) | 1.1 | (28.6) | (29.9) |
Net loss | $ (263.3) | $ (112.0) | $ (27.2) |
Net loss per share: | |||
Basic (in dollars per share) | $ (3.18) | $ (1.39) | $ (0.35) |
Diluted (in dollars per share) | $ (3.18) | $ (1.39) | $ (0.35) |
Weighted average shares outstanding: | |||
Basic (in shares) | 82.8 | 80.6 | 78.0 |
Diluted (in shares) | 82.8 | 80.6 | 78.0 |
Testing Revenue | |||
Total revenue | $ 753.2 | $ 678.4 | $ 666.4 |
Costs and expenses: | |||
Costs and expenses | 236.2 | 202.0 | 185.7 |
Other revenue | |||
Total revenue | 0.0 | 0.0 | 24.2 |
Costs and expenses: | |||
Costs and expenses | $ 0.0 | $ 0.0 | $ 11.9 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 132.1 | $ 56.9 |
Marketable investment securities | 8.8 | 58.0 |
Trade accounts receivable | 114.3 | 101.6 |
Inventory | 22.0 | 20.1 |
Prepaid taxes | 17.0 | 17.6 |
Prepaid expenses and other current assets | 19.4 | 20.4 |
Total current assets | 313.6 | 274.6 |
Operating lease right-of-use assets | 61.6 | 103.9 |
Long-term marketable investment securities | 0.0 | 54.8 |
Property, plant and equipment, net | 119.0 | 83.4 |
Intangibles, net | 349.5 | 379.7 |
Goodwill | 287.4 | 286.8 |
Other assets | 15.4 | 15.5 |
Total assets | 1,146.5 | 1,198.7 |
Current liabilities: | ||
Accounts payable | 25.8 | 28.8 |
Accrued liabilities | 113.9 | 94.3 |
Current maturities of operating lease liabilities | 16.2 | 14.1 |
Total current liabilities | 155.9 | 137.2 |
Unrecognized tax benefits | 30.2 | 26.8 |
Long-term debt | 38.5 | 0.0 |
Noncurrent operating lease liabilities | 97.4 | 130.9 |
Other long-term liabilities | 41.3 | 18.0 |
Total liabilities | 363.3 | 312.9 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock, $0.01 par value, 89.9 and 81.2 shares outstanding at December 31, 2023 and 2022, respectively | 0.9 | 0.8 |
Additional paid-in capital | 1,415.5 | 1,260.1 |
Accumulated other comprehensive loss | (3.7) | (8.9) |
Accumulated deficit | (629.5) | (366.2) |
Total stockholders' equity | 783.2 | 885.8 |
Total liabilities and stockholders’ equity | $ 1,146.5 | $ 1,198.7 |